NCT01903798View on ClinicalTrials.gov

A Safety and Efficacy Study of Mycophenolate Mofetil and Rilonacept in Patients With Alcoholic Hepatitis

PHASE2CompletedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions
Alcoholic Hepatitis
Interventions
DRUG

Mycophenolate mofetil

Immunosuppressive agent

DRUG

Prednisolone

Corticosteroid

DRUG

Rilonacept

Trial Locations (3)

90033

LAC USC Medical Center, Los Angeles

90509

Harbor-UCLA Medical Center, Torrance

90822

VA Long Beach Healthcare System, Long Beach

All Listed Sponsors
collaborator

University of Southern California

OTHER

collaborator

Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

OTHER

collaborator

VA Long Beach Healthcare System

FED

collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

Southern California Institute for Research and Education

OTHER

NCT01903798 - A Safety and Efficacy Study of Mycophenolate Mofetil and Rilonacept in Patients With Alcoholic Hepatitis | Biotech Hunter | Biotech Hunter